OMPEKIMIG
UNII 7S9F79AD9Z

Substance Identification & Data

This profile provides standardized clinical and technical data for Ompekimig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7S9F79AD9Z.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2981477-39-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

7S9F79AD9Z

CAS Registry Number

2981477-39-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

OMPEKIMIG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C211744

National Cancer Institute reference terminology for clinical and research data.

INN ID

13515

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

MN-110

Identifier assigned by the United States Adopted Names Council.

Substance Type

Ompekimig

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ompekimig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

Ompekimig

Common Names & Synonyms

Immunoglobulin, anti-(human/Macaca fascicularis interleukin 13) (human-Mus musculus monoclonal PF-07296735 κ-chain) fusion protein with peptide linker (GGGGS) fusion protein with immunoglobulin G1 [448-glutamic acid,461-alanine,462-alanine,464-alanine,595-glutamic acid,655-leucine,661-serine] anti-(human/Macaca fascicularis interleukin 4) (human-Mus musculus monoclonal PF-07296735 γ1-chain), (Cys453→Cys230′),(Cys456→Cys233′)-bis(disulfide) with immunoglobulin G1 [225-arginine,238-alanine,239-alanine,241-alanine,413-arginine,432-leucine,438-serine] anti-(human/Macaca fascicularis interleukin 33) (human-Sprague-Dawley rat monoclonal PF-07275307 γ1-chain), (Cys218→Cys-221")-disulfide with immunoglobulin anti-(human/Macaca fascicularis interleukin 13) (recombinant heavy chain variable-constant domain 1) fusion protein with peptide linker (EPKSC), (Cys447→Cys218′′′)-disulfide with immunoglobulin anti-(human/Macaca fascicularis interleukin 4) (human-Mus musculus monoclonal PF-07296735 κ-chain), (Cys224′→Cys213′′′′)-disulfide with immunoglobulin anti-(human/Macaca fascicularis interleukin 33) (human-Sprague-Dawley rat monoclonal PF-07275307 κ-chain) (Cys453→Cys230′),(Cys456→Cys233′)-bis(disulfide) with immunoglobulin G1 [225-arginine,238-alanine,239-alanine,241-alanine,413-arginine,432-leucine,438-serine] anti-(human/Macaca fascicularis interleukin 33) (human-Sprague-Dawley rat monoclonal PF-07275307 γ1-chain), (Cys218→Cys-221”)-disulfide with immunoglobulin anti-(human/Macaca fascicularis interleukin 13) (recombinant heavy chain variable-constant domain 1) fusion protein with peptide linker (EPKSC), (Cys447→Cys218′′′)-disulfide with immunoglobulin anti-(human/Macaca fascicularis interleukin 4) (human-Mus musculus monoclonal PF-07296735 κ-chain), (Cys224′→Cys213′′′′)-disulfide with immunoglobulin anti-(human/Macaca fascicularis interleukin 33) (human-Sprague-Dawley rat monoclonal PF-07275307 κ-chain)

OMPEKIMIG [USAN]

ompekimig [INN]